187 related articles for article (PubMed ID: 17017547)
21. The course of olfactory deficits in patients with Parkinson's disease--a study based on psychophysical and electrophysiological measures.
Meusel T; Westermann B; Fuhr P; Hummel T; Welge-Lüssen A
Neurosci Lett; 2010 Dec; 486(3):166-70. PubMed ID: 20858529
[TBL] [Abstract][Full Text] [Related]
22. Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease.
Berendse HW; Roos DS; Raijmakers P; Doty RL
J Neurol Sci; 2011 Nov; 310(1-2):21-4. PubMed ID: 21705022
[TBL] [Abstract][Full Text] [Related]
23. Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson's disease.
Domellöf ME; Lundin KF; Edström M; Forsgren L
Parkinsonism Relat Disord; 2017 May; 38():41-47. PubMed ID: 28242255
[TBL] [Abstract][Full Text] [Related]
24. Altered activation patterns within the olfactory network in Parkinson's disease.
Moessnang C; Frank G; Bogdahn U; Winkler J; Greenlee MW; Klucken J
Cereb Cortex; 2011 Jun; 21(6):1246-53. PubMed ID: 21047984
[TBL] [Abstract][Full Text] [Related]
25. The diagnostic value of dopamine transporter imaging and olfactory testing in patients with parkinsonian syndromes.
Georgiopoulos C; Davidsson A; Engström M; Larsson EM; Zachrisson H; Dizdar N
J Neurol; 2015 Sep; 262(9):2154-63. PubMed ID: 26122543
[TBL] [Abstract][Full Text] [Related]
26. Olfactory dysfunction in Parkinson's disease.
Kranick SM; Duda JE
Neurosignals; 2008; 16(1):35-40. PubMed ID: 18097158
[TBL] [Abstract][Full Text] [Related]
27. The human olfactory system in two proteinopathies: Alzheimer's and Parkinson's diseases.
Ubeda-Bañon I; Saiz-Sanchez D; Flores-Cuadrado A; Rioja-Corroto E; Gonzalez-Rodriguez M; Villar-Conde S; Astillero-Lopez V; Cabello-de la Rosa JP; Gallardo-Alcañiz MJ; Vaamonde-Gamo J; Relea-Calatayud F; Gonzalez-Lopez L; Mohedano-Moriano A; Rabano A; Martinez-Marcos A
Transl Neurodegener; 2020 Jun; 9(1):22. PubMed ID: 32493457
[TBL] [Abstract][Full Text] [Related]
28. Olfactory bulb volumes in patients with idiopathic Parkinson's disease a pilot study.
Mueller A; Abolmaali ND; Hakimi AR; Gloeckler T; Herting B; Reichmann H; Hummel T
J Neural Transm (Vienna); 2005 Oct; 112(10):1363-70. PubMed ID: 15711853
[TBL] [Abstract][Full Text] [Related]
29. Odor selectivity of hyposmia and cognitive impairment in patients with Parkinson's disease.
Mao CJ; Wang F; Chen JP; Yang YP; Chen J; Huang JY; Liu CF
Clin Interv Aging; 2017; 12():1637-1644. PubMed ID: 29070942
[TBL] [Abstract][Full Text] [Related]
30. Association of olfactory bulb volume and olfactory sulcus depth with olfactory function in patients with Parkinson disease.
Wang J; You H; Liu JF; Ni DF; Zhang ZX; Guan J
AJNR Am J Neuroradiol; 2011 Apr; 32(4):677-81. PubMed ID: 21330398
[TBL] [Abstract][Full Text] [Related]
31. The use of olfactory testing when diagnosing Parkinson's disease - a systematic review.
Nielsen T; Jensen MB; Stenager E; Andersen AD
Dan Med J; 2018 May; 65(5):. PubMed ID: 29726318
[TBL] [Abstract][Full Text] [Related]
32. Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study.
Vaswani PA; Morley JF; Jennings D; Siderowf A; Marek K;
Parkinsonism Relat Disord; 2022 Nov; 104():15-20. PubMed ID: 36194902
[TBL] [Abstract][Full Text] [Related]
33. Association of olfactory dysfunction with risk for future Parkinson's disease.
Ross GW; Petrovitch H; Abbott RD; Tanner CM; Popper J; Masaki K; Launer L; White LR
Ann Neurol; 2008 Feb; 63(2):167-73. PubMed ID: 18067173
[TBL] [Abstract][Full Text] [Related]
34. Olfaction as an early marker of Parkinson's disease and Alzheimer's disease.
Walker IM; Fullard ME; Morley JF; Duda JE
Handb Clin Neurol; 2021; 182():317-329. PubMed ID: 34266602
[TBL] [Abstract][Full Text] [Related]
35. Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease.
Bohnen NI; Gedela S; Kuwabara H; Constantine GM; Mathis CA; Studenski SA; Moore RY
J Neurol; 2007 Jan; 254(1):84-90. PubMed ID: 17508142
[TBL] [Abstract][Full Text] [Related]
36. Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity.
Bohnen NI; Gedela S; Herath P; Constantine GM; Moore RY
Neurosci Lett; 2008 Dec; 447(1):12-6. PubMed ID: 18838108
[TBL] [Abstract][Full Text] [Related]
37. Olfactory system pathology as a model of Lewy neurodegenerative disease.
Duda JE
J Neurol Sci; 2010 Feb; 289(1-2):49-54. PubMed ID: 19783257
[TBL] [Abstract][Full Text] [Related]
38. Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson's disease patients.
Huisman E; Uylings HB; Hoogland PV
Mov Disord; 2008 Jul; 23(10):1407-13. PubMed ID: 18581481
[TBL] [Abstract][Full Text] [Related]
39. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson's disease: clues to early diagnosis and effective treatment.
Bang Y; Lim J; Choi HJ
Arch Pharm Res; 2021 Jun; 44(6):588-604. PubMed ID: 34145553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
